Table 4 NPVs of serum LRG and CRP for endoscopic moderate activity (SES-CD ≥ 7) in clinical remission and non-remission phases.

From: Leucine-rich Alpha-2 glycoprotein could be clinically useful in active and postoperative Crohn’s disease

 

Cut-off value

Sensitivity

Specificity

Prevalence

NPV

LRG

10.0 µg/mL

0.98

0.23

10%

0.99

50%

0.92

CRP

0.04 mg/dL

0.85

0.53

10%

0.97

50%

0.78

  1. SES-CD: simplified endoscopic score for Crohn’s disease; LRG, leucine-rich alpha-2 glycoprotein; CRP, C-reactive protein; NPV, negative predictive value.
Back to article page